• LAST PRICE
    63.2300
  • TODAY'S CHANGE (%)
    Trending Up0.0900 (0.1425%)
  • Bid / Lots
    63.2300/ 2
  • Ask / Lots
    63.2400/ 7
  • Open / Previous Close
    62.7800 / 63.1400
  • Day Range
    Low 62.7300
    High 63.3100
  • 52 Week Range
    Low 57.1650
    High 74.1200
  • Volume
    932,485
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 63.14
TimeVolumeGILD
09:32 ET11433063.17
09:34 ET1225363.23
09:36 ET2289763.12
09:38 ET1657262.945
09:39 ET1250663.0124
09:41 ET1564162.97
09:43 ET2059563.03
09:45 ET2357062.94
09:48 ET2775962.8765
09:50 ET1669262.87
09:52 ET1140962.94
09:54 ET2045363.02
09:56 ET1710863.06
09:57 ET1378563.13
09:59 ET861263.17
10:01 ET1293963.0544
10:03 ET2945763.08
10:06 ET1520363.145
10:08 ET1621463.19
10:10 ET1334663.27
10:12 ET1780263.29
10:14 ET845663.24
10:15 ET1119763.19
10:17 ET1252263.18
10:19 ET1161963.16
10:21 ET1331463.215
10:24 ET1662763.21
10:26 ET1729463.21
10:28 ET1407863.17
10:30 ET933963.15
10:32 ET1564863.23
10:33 ET1511363.25
10:35 ET1296063.265
10:37 ET1562563.2
10:39 ET1273063.17
10:42 ET2105763.24
10:44 ET1742163.23
10:46 ET385363.23
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGILD
Gilead Sciences Inc
79.1B
19.3x
-13.08%
United StatesMRNA
Moderna Inc
68.2B
5.5x
---
United StatesREGN
Regeneron Pharmaceuticals Inc
69.9B
12.7x
+56.36%
United StatesBNTX
BioNTech SE
39.1B
3.5x
---
United StatesVRTX
Vertex Pharmaceuticals Inc
75.9B
24.0x
---
United StatesIQV
IQVIA Holdings Inc
44.7B
40.7x
+59.92%
As of 2022-08-11

Company Information

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases includes Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. It sells and distributes its products in the United States through the wholesale channel. It operates in more than 35 countries worldwide.

Contact Information

Headquarters
333 LAKESIDE DRFOSTER CITY, CA, United States 94404
Phone
650-574-3000
Fax
650-578-9264

Executives

Chairman of the Board, Chief Executive Officer
Daniel O'Day
Chief Financial Officer
Andrew Dickinson
Executive Vice President - Corporate Affairs, General Counsel, Corporate Secretary
Deborah Telman
Executive Vice President - Pharmaceutical Development and Manufacturing
Stacey Ma
Executive Vice President - Research
Flavius Martin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$79.1B
Revenue (TTM)
$27.5B
Shares Outstanding
1.3B
Dividend Yield
4.62%
Annual Dividend Rate
2.9200 USD
Ex-Dividend Date
09-14-22
Pay Date
09-29-22
Beta
0.36
EPS
$3.28
Book Value
$16.80
P/E Ratio
19.3x
Price/Sales (TTM)
2.9
Price/Cash Flow (TTM)
12.7x
Operating Margin
25.47%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.